PATH vs VERU · P/E 19, rev $1.61B vs rev $16.9M
Uipath Inc (PATH) versus Veru Inc (VERU) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Veru Inc (VERU) is a biotechnology company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported VERU revenue for 2024-09-30 was $16.9M. Net income was -$37.8M. Revenue was up 3.6% from 2023-09-30 to 2024-09-30. VERU currently screens at market cap $48.7M.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. VERU currently screens at market cap $48.7M.
Not investment advice. Open the PATH and VERU stock pages for the full models.
Not investment advice.